Medicinal Cannabis Matters: Friday Roundup - 21 August 2026

Patient Experiences Highlight the Difference Treatment Can Make

A new BBC article explores the experiences of people using medicinal cannabis in the UK, including the story of Billy, a patient living with a long-term health condition who describes how treatment has helped him regain a sense of stability in his daily life.

Billy’s experience reflects many patients’ situations, that accessing medicinal cannabis is not just about managing individual symptoms, but about improving overall quality of life. In his case, he highlights how treatment has supported him in coping with ongoing health challenges and has had a meaningful impact on his day-to-day functioning.

Patient stories like Billy’s are an important part of the wider conversation around medicinal cannabis. While everyone’s experience is different, hearing directly from people who have accessed treatment can help challenge misconceptions and provide a more realistic picture of what living with a legal medicinal cannabis prescription can look like.

Two Years of Data Shows Continued Improvements for Endometriosis Patients

New analysis from the UK Medical Cannabis Registry has followed 101 patients with endometriosis over a two-year period, providing some of the longest-term data available on medicinal cannabis treatment for the condition.

The study found improvements across measures of pain, quality of life, anxiety and sleep at every follow-up point, from one month through to 24 months. Researchers also reported a reduction in the median prescribed opioid dose over the two-year period, falling from 19.9mg to 14.8mg of oral morphine equivalents per day.

These findings are encouraging for people living with endometriosis, a condition that can cause significant and persistent pain.

The Research on Medicinal Cannabis and Inflammatory Bowel Disease

A new survey from researchers at the University of Florida has explored the experiences of 108 people living with Crohn's disease or ulcerative colitis.

The survey found that 87.6% of respondents reported an improvement in their quality of life after using cannabis, while 61.3% said it had helped them live more independently. More than half, 59%, also believed cannabis had reduced the amount of opioid medication they needed.

Symptoms most commonly reported as improving included anxiety, joint pain, nausea and insomnia. This study adds to increased patient-reported evidence around cannabis and inflammatory bowel disease.

It’s true that patient experiences help us understand what treatment can mean in everyday life, while longer-term research helps doctors and researchers build a clearer picture of potential benefits or areas where further evidence is needed.

For conditions such as endometriosis and inflammatory bowel disease, where patients can experience persistent symptoms and may have limited treatment options, continuing to invest in high-quality research is particularly important.

If you're considering whether medicinal cannabis may be suitable for your condition, you can check your eligibility online in just two minutes. It's confidential and provides a straightforward starting point before speaking with a specialist prescribing doctor.

Disclaimer: This blog post and the following featured articles are for information only and any articles on external platforms may be amended at any time. Articles that we refer to in our weekly roundup do not reflect the views of Medicann.